Member Login
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

    Investing Articles

    Should you buy GlaxoSmithKline plc after its change in CEO?

    | Peter Stephens

    Is GlaxoSmithKline plc (LON: GSK) more or less appealing after a change in senior management?

    Read more »

    Investing Articles

    Is this the best healthcare stock money can buy after today’s update?

    | Peter Stephens

    Should you buy this stock or a sector peer following today's news?

    Read more »

    Investing Articles

    These FTSE 100 giants sank in August! Can they bounce back?

    | Royston Wild

    Royston Wild looks at the share price prospects of three recent FTSE 100 (INDEXFTSE: UKX) fallers.

    Read more »

    Investing Articles

    Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?

    | Edward Sheldon, CFA

    Edward Sheldon looks at Hikma Pharmaceuticals plc's (LON: HIK) interim results statement and examines whether the long-term growth story is…

    Read more »

    Investing Articles

    Is this stock the best buy in its sector following today’s update?

    | Peter Stephens

    Should you buy this stock over two industry peers?

    Read more »

    Investing Articles

    Do today’s updates make these big fallers a buy?

    | Roland Head

    Are today's big losers buying opportunities, or falling knives?

    Read more »

    Investing Articles

    Is it too late to buy rapid risers ARM Holdings plc, WPP plc ord 10p and Hikma Pharmaceuticals plc?

    | Edward Sheldon, CFA

    Edward Sheldon looks at whether it's too late to buy fast movers ARM Holdings plc (LON: ARM), WPP plc ord…

    Read more »

    Investing Articles

    3 Brexit-resistant shares

    | Kevin Godbold

    These three companies look well placed to avoid Brexit fallout.

    Read more »

    Investing Articles

    3 top pharma stocks immune to Brexit: AstraZeneca plc, Shire plc and Hikma Pharmaceuticals plc

    | Bilaal Mohamed

    Bilaal Mohamed looks at three pharmaceuticals plays that could offer shelter from Brexit panic: AstraZeneca plc (LON: AZN), Shire plc…

    Read more »

    Investing Articles

    Earnings are set to sink at Burberry Group plc, Hikma Pharmaceuticals plc and J Sainsbury plc! Should you buy?

    | Royston Wild

    Royston Wild runs the rule over FTSE 100 (INDEXFTSE: UKX) strugglers Burberry Group plc (LON: BRBY), Hikma Pharmaceuticals plc (LON:…

    Read more »

    Investing Articles

    Should you buy or sell Majestic Wines plc, Enquest plc and Hikma Pharmaceuticals plc after today’s news?

    | Roland Head

    Roland Head takes a closer look at today's news from Majestic Wines plc (LON:WINE), Enquest plc (LON:ENQ) and Hikma Pharmaceuticals…

    Read more »

    Investing Articles

    Hikma Pharmaceuticals plc set for FTSE 100 re-entry and Inmarsat plc for ejection

    | G A Chester

    Hikma Pharmaceuticals plc (LON:HIK) is expected to join the FTSE 100 (INDEXFTSE:UKX), with Inmarsat plc (LON:ISAT) set for the boot.

    Read more »